FDA Inspection 1213026 — C2C Development, LLC
The FDA completed an inspection of C2C Development, LLC on August 3, 2023 in Melbourne, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 3, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Melbourne, FL (United States)